TYME TECHNOLOGIES INC(NASDAQ:TYME) stock News

TYME Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Benzinga - Mentions: BEAT NRBO QTNT TENX ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

3 years ago - By: InvestorPlace - Mentions: NBRV AMPX AAOI SYRS ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

3 years ago - By: Benzinga - Mentions: SCPS NBY FSRD BEAT ...

Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket

3 years ago - By: TYME Technologies, Inc.

Syros and Tyme Technologies Announce Stockholder Approval of Merger

3 years ago - By: Syros Pharmaceuticals, Inc. - Mentions: SYRS

Syros and Tyme Technologies Announce Stockholder Approval of Merger

3 years ago - By: InvestorPlace - Mentions: AKRO CMRA SYRS ETNB ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

3 years ago - By: TYME Technologies, Inc.

TYME Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS Recommend Stockholders Vote “FOR” Proposed Merger of Syros and Tyme

3 years ago - By: Kahn Swick & Foti, LLC

TYME TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME

3 years ago - By: Weiss Law - Mentions: SYRS

SHAREHOLDER ALERT: Weiss Law Investigates Syros Pharmaceuticals, Inc.

3 years ago - By: Kahn Swick & Foti, LLC

TYME TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME

3 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether TYME Technologies, Inc. has obtained a Fair Price in its transaction with Syros

3 years ago - By: Syros Pharmaceuticals - Mentions: SYRS

Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement

3 years ago - By: TYME Technologies, Inc.

TYME Technologies, Inc. Reports Fourth Fiscal Quarter and Full Year 2022 Financial and Operating Results

4 years ago - By: Tyme Technologies, Inc.

TYME Technologies, Inc. Announces Exploration of Strategic Options

4 years ago - By: Tyme Technologies, Inc.

TYME Technologies, Inc. Announces Changes to its Board of Directors

4 years ago - By: Tyme Technologies, Inc.

TYME Technologies, Inc. Announces SM-88 Poster at the American Association for Cancer Research (AACR) Annual Meeting 2022

4 years ago - By: TYME Technologies, Inc.

TYME Technologies, Inc. Provides Business Update and Announces Third Fiscal Quarter 2022 Financial and Operating Results

4 years ago - By: TYME Technologies, Inc.

TYME TECHNOLOGIES INC (TYME) Stock News

TYME Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Friday's Pre-Market Session

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket

Syros and Tyme Technologies Announce Stockholder Approval of Merger

Syros and Tyme Technologies Announce Stockholder Approval of Merger

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

TYME Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS Recommend Stockholders Vote “FOR” Proposed Merger of Syros and Tyme

TYME TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME

SHAREHOLDER ALERT: Weiss Law Investigates Syros Pharmaceuticals, Inc.

TYME TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME

Shareholder Alert: Ademi LLP investigates whether TYME Technologies, Inc. has obtained a Fair Price in its transaction with Syros

Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement

TYME Technologies, Inc. Reports Fourth Fiscal Quarter and Full Year 2022 Financial and Operating Results

TYME Technologies, Inc. Announces Exploration of Strategic Options

TYME Technologies, Inc. Announces Changes to its Board of Directors

TYME Technologies, Inc. Announces SM-88 Poster at the American Association for Cancer Research (AACR) Annual Meeting 2022

TYME Technologies, Inc. Provides Business Update and Announces Third Fiscal Quarter 2022 Financial and Operating Results

TYME Technologies, Inc. to Host Conference Call and Webcast on Friday, February 11, at 8:30 AM ET